Gboxin is an Oxidative Phosphorylation Inhibitor That Targets Glioblastoma
According to the World Health Organization (WHO), Glioblastoma is the most common primary brain neoplasm. It comprises 15% of all intracranial neoplasms and 60-75% of astrocytic tumors. Unfortunately, Glioblastoma is…